United States: Whooping cough is currently affecting California due to a nationwide trend, according to the CDC. And it’s causing anxiety to those affected most by this bacterial disease risk.
More about the news
It is transmitted through aerosols that can survive on fabrics and surfaces for up to five days.
It starts with flu-like symptoms, such as fever and cough, which may develop, and severe coughing spells that may last for weeks.
The most horrifying sound of the cough is when young lungs are struggling to breathe – the cohort most at risk from the disease.
Some signs include inflammation of the upper respiratory system due to a cough that comes out like a ‘whoop, sneezing, and a blocked nose.
According to Dr. Gabrielle Pina, a pediatric hospitalist at Loma Linda University Children’s Health, Pertussis is “called whooping cough because as the diaphragm squeezes the lungs to try to get all that stuff out, it forcefully pushes the lungs up,” abc7.com reported.

What are the experts stating?
According to the source, the Center for Disease Control reported cases of whooping cough hit a 10-year high with more than 17000 reports.
There are currently five times as many cases in America as there were last year, with many in California.
“It looks like it’s coming back with a vengeance,” Pina added.
Pertussis is showing an upward trend and is on the virtual cusp of rising as it was when masks and social distancing were the norm and when many families opted out of vaccinating their children.
“If you are in a community that does not get regularly vaccinated, you’re at high risk for getting these vaccine-preventable illnesses like pertussis,” she added.

It is now established that children below one year are at higher risk of getting an infection and complications that need a hospital visit; a third of them are likely to be hospitalized.
Moreover, whooping cough, which is a respiratory tract infection, can only be controlled with antibiotics to stop the bacteria’s spread.
Immunocompromised and elderly people require Tdap 10 years after the initial administration; pregnant women are encouraged to take Tdap at 27 weeks of pregnancy.
“Because we really want those third-trimester stores of the antibodies to cross into the babies so that they have the most protection,” said Pina.